Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Applied Biosystems
New assays enable detection, quantification of regulatory molecules
October 9th, 2005
Applied Biosystems (ABI), an Applera Corp. business, announced the commercial release of its TaqMan microRNA Assays for the detection and quantitation of mature human microRNA (miRNA) expression levels, a promising new area of genomic research. MicroRNAs are a recently discovered class of small RNA molecules known to play a powerful regulatory role in cell differentiation, developmental biology, and diseases such as cancer. "The commercial availability of our TaqMan microRNA Assays has been much anticipated in the industry. These novel assays eliminate major challenges in detecting and quantifying miRNAs and are expected to stimulate research in...
Source: Managed Care Law Weekly (2005-10-09)
|
